Type to search

FDA Approves Roche’s Evrysdi for Use in Babies Under Two Months With Spinal Muscular Atrophy (SMA) | Pharmtech Focus
FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder | Pharmtech Focus
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue | Pharmtech Focus